Entity Details

Primary name S13A5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ86YT5
EntryNameS13A5_HUMAN
FullNameSolute carrier family 13 member 5
TaxID9606
Evidenceevidence at protein level
Length568
SequenceStatuscomplete
DateCreated2006-11-28
DateModified2021-06-02

Ontological Relatives

GenesSLC13A5

GO terms

Show/Hide Table
GOName
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0015137 citrate transmembrane transporter activity
GO:0015141 succinate transmembrane transporter activity
GO:0015746 citrate transport
GO:0016021 integral component of membrane
GO:0017153 sodium:dicarboxylate symporter activity
GO:0098656 anion transmembrane transport

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001898 Solute carrier family 13FamilyFamily
IPR031312 Sodium/sulphate symporter, conserved siteSiteConserved site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615905 OMIMDevelopmental and epileptic encephalopathy 25, with amelogenesis imperfecta (DEE25)An autosomal recessive disease characterized by subclinical seizures appearing in the first days of life, evolving to severe epileptic disease. Affected individuals have profound or severe delayed development with lack of speech, and most patients do not acquire the ability to sit. Additional variable features include axial hypotonia, peripheral hypertonia, and abnormal involuntary movements such as dystonia and choreoathetosis. Dental abnormalities, including delayed eruption, hypodontia, tooth hypoplasia, yellow discoloration, thin enamel, and enamel chipping are observed in most patients. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB09154 Sodium citrateSwissprotsmall molecule